or gel filtration (4) is useful, but these techniques are cumbersome. Another approach is to detect virus-specific IgM by using labeled anti-human IgM in immunofluorescence (3), radioimmunoassay (6), or enzyme immunoassay (EIA) (9). Unfortunately, the specificity of these tests can be impaired by the presence of rheumatoid factor (7, 14) . Furthermore, the sensitivity of immunofluorescence can be reduced by competition for antigen between IgM and IgG, which are usually both present in the serum sample.
cific antibody of the immunoglobulin M (IgM) class. The separation of IgM from IgG by sucrose density gradient centrifugation (DGC) (3, 17) or gel filtration (4) is useful, but these techniques are cumbersome. Another approach is to detect virus-specific IgM by using labeled anti-human IgM in immunofluorescence (3), radioimmunoassay (6), or enzyme immunoassay (EIA) (9) . Unfortunately, the specificity of these tests can be impaired by the presence of rheumatoid factor (7, 14) . Furthermore, the sensitivity of immunofluorescence can be reduced by competition for antigen between IgM and IgG, which are usually both present in the serum sample.
Another rapid method involves the treatment of serum by staphylococcal protein A, which removes about 95% of IgG (1) . However, protein A fails to remove the IgG3 subclass and removes 10 to 15% of IgM (15) . More recently, the use of solid-phase immunosorbents was extended to the separation of IgM from whole serum immunoglobulins (2) . In this laboratory, we evaluated for the detection of rubella-specific IgM antibody a solid-phase reverse immunosorbent test (SPRIST) based on the addition of rubella hemagglutinin (HA). In the present report, the results are compared with those of the sucrose DGC method.
MATERIALS AND METHODS Sera. (i) Retrospective study. A total of 157 sera which were received during the last 3 years for rubella IgM antibody testing by the sucrose DGC technique were examined. Among them, 47 sera were drawn from 28 subjects (20 pregnant women, 4 newborns, and 4 children) with clinical symptoms of rubella infection (rash, involvement of lymph nodes, arthralgia, or congenital rubella). A total of 19 paired sera were available, 12 of which demonstrated seroconversions, and 7 of which exhibited high stable titers (>1:640). The remaining 9 sera were single, with antibody titers of >1:320. All sera were collected from day 1 to day 32 after the clinical onset. Eight sera were obtained from two previously seronegative young women who received a recent rubella vaccination (RA27/3 Rudivax; Merieux, France). For the first vaccinated woman, sera were collected at days 10, 22, 38, and 85, and for the second, sera were collected at days 10, 28, 64, and 98 postimmunization. A total of 102 sera were collected from pregnant women without any symptoms of rubella but who demonstrated moderate to high rubella antibody titers (1:160 to 1:2,560).
In addition, 24 sera with positive rheumatoid factor (Waaler-Rose test positive, ranging in titer between 1: 64 and 1:2,048), 15 sera from patients with infectious mononucleosis (Paul-Bunnell-Davidsohn test positive), and 20 sera from individuals with a recent measles infection (measles-specific IgM positive) were also 698 on October 25, 2017 by guest http://jcm.asm.org/ Downloaded from assayed.
All sera were aseptically dispensed and stored at -60°C before testing.
(ii) Prospective study. A total of 592 sera which were received in the laboratory for routine rubella antibody determinations were assayed. The hemagglutination inhibition (HI) antibody titers ranged from <1:10 to 1:2,560.
HI test (16) . All rubella antibody titers indicated above were obtained by HI. Nonspecific inhibitors were removed by treatment with kaolin in borate buffer (pH 9) (12) , and the heteroagglutinins were absorbed with a 50% adult chicken erythrocyte (RBC) suspension. A micromethod was performed by using 0.05 ml of serum dilution (starting dilution, 1:10), 4 (ài) Pretitration and testing ofthe specificity of anti-human IgM used for solid-phase coating. Although the specificity of all labeled or nonlabeled anti-human IgM or IgG used in this laboratory was satisfactory as determined by immunoelectrophoresis, an additional control experiment was performed as follows. Plates were coated as described above with increasing dilutions (1:200 to 1:12,800) of anti-human IgM (12 wells per dilution). Then 0.1 ml of human serum dilutions (1:20 to 1:20,480) in phosphatebuffered saline-0.05% Tween 20 and 1% bovine serum albumin were added to each dilution of anti-human IgM, except for one row, which served as controls. After 2 h at 37°C and extensive washing, the wells were filled with 0.1 ml of either peroxidase-labeled anti-human IgM or IgG (Cappel Laboratories) at an optimal dilution as determined in EIA, i.e., 1:300 and 1:500, respectively. After 2 h at 37°C and washing, the enzyme activity was detected by a color change in a solution containing H202 and 5-aminohydroxybenzoic acid (11) . Readings were made after 30 min at 450 nm with a Multiscan apparatus (Flow Laboratories, Inc., Rockville, Md).
(iii) Determination of the optimal concentration of anti-IgM coating antibody, rubella HA, and chicken RBC suspension. Based upon results of the specificity test described above, the plates were coated with various dilutions of anti-IgM (1:200 to 1: 3,200). After extensive washing, sera (previously absorbed with chicken RBC) were diluted from 1:20 to 1:20,480, and 0.1 ml of each dilution was added to the sensitized wells. For standardization of the test, one rubella IgM-positive serum and one negative serum, as demonstrated by DGC, were used. After 2 h at 37°C, the plates were washed. A 0.05-ml amount of a rubella HA dilution in borate-bovine serum albumin buffer saline (pH 9) and 0.1 ml of chicken RBC suspension in phosphate-buffered saline (pH 6.2) were successively added to each well. Increasing concentrations of HA (1, 2, 4, 6, and 8 U) and RBC suspension (0.20,0.40,0.60,0.80, and 1%) were evaluated. A serum control (1:20 serum dilution without HA and with RBC) and a control of HA activity (dilutions of HA without serum and with RBC) were included. After gentle shaking at 4°C for 30 min, the plates were held at 20°C until the RBC were completely settled in the serum controls. Two patterns were observed: a strong hemagglutination with a clumping RBC which flowed when the plate was tilted ( (i) Coating procedure. By using an EIA method as described above, the influence of two different buffers on the anti-IgM coating procedure was examined (Fig. 2) . It appeared that the coating was slightly better with the carbonate buffer (pH 9.6) than with the TSA buffer (pH 7.4) . Furthermore, the reproducibility of the coating was increased when the alkaline buffer was used. The influence of the concentration of the coating antibody was evaluated by using increasing dilutions of anti-IgM. demonstrated when a peroxidase-labeled antiIgG was added, resulting in a colored reaction no different from that of the background. The anti-human IgM's were from two different commercial sources, and they gave approximately the same results.
(ii) Determination of optimal concentrations of anti-IgM, rubella HA, and RBC suspension. The best results, i.e., the maximum pattern difference between the IgM-positive and IgM-negative samples, were obtained by using 6 to 8 HA U and a 0.60% RBC suspension. The reaction was uninterpretable with only 1 3, 7, 17, and 29) . Ail of the positive results obtained by SPRIST were negative after the sera were treated with 2-ME. With the 102 sera drawn from women who had no symptoms of recent rubella infection and were DGC negative, no positive results were demonstrated with SPRIST (titer, <1:20). Table 3 shows the comparative results obtained when sera collected from vaccinated women were tested. The presence of specific IgM was demonstrated by both methods, and the duration of IgM after the rubella vaccination was identical, except for the last serum (day 85) of patient 1, which was DGC negative and exhibited a low titer (1:80) by SPRIST.
Rheumatoid factor, heterophil antibody, or measles IgM antibody did not seem to interfere in the rubella SPRIST since all sera from these groups were found negative. They were also negative when rubella IgM detection was performed by DGC. Prospective study. Of 592 sera which were at random and tested by DGC for rubella IgM, received for routine rubella HI antibody deter-with negative (<1:4) results (Table 4) . mination and were prospectively examined for rubella IgM by SPRIST, 8 were found positive, DISCUSSION and the positive titers were abolished by 2-ME The technique of capturing IgM by anti-hutreatment. When tested by DGC, seven sera man IgM adsorbed to the solid phase has been were found positive, and one serum contained evaluated by several authors (2, 10) . Krech and only a trace of IgM (1:2) . After obtaining clinical Wilhelm (5) previously described a SPRIST for information, it appeared that six patients suf-the rapid demonstration of rubella IgM. A 1-U fered from a recent infection resembling rubella, amount of HA was used, and HI was observed one was recently vaccinated for rubella, and one for the IgM-positive samples. Our test seemed was asymptomatic. Among the remaining 584 to be rather different. Positive sera caused adsera found negative by SPRIST, 72 were taken sorption of RBC onto the bottom of the well, 702 DENOYEL,' GASPAR, AND PEYRAMOND The IgM antibody titers detected with SPRIST were 20-to 1,000-fold higher than those obtained with DGC. Furthermore, low SPRISTpositive titers were detected in a few cases when HI or DGC titers were negative. Since the positive reactions regularly disappeared after 2-ME treatment, they probably resulted from the increased sensitivity of SPRIST. Concerning the duration of specific rubella IgM, DGC and SPRIST gave comparable results for the two vaccinated women. Unfortunately, we were not able to test successive sera after a naturally acquired infection. It is possible that an occasional prolonged IgM response might be observed (8) . In our experience, we have seen no such results which would hamper the value of the method for determining a recent infection, since all positive results were obtained with sera taken no more than 60 days after infection and 98 days after vaccination. Nevertheless, further study with sera taken later after the onset of rubella is required to confirm this point.
From the above data, it appeared that no false-positive results were obtained with SPRIST. The major drawback of the technique was the possible occurrence of false-negative results due to the occasional lack of fixation of the anti-IgM onto the plastic wells. Although we selected plates which gave optimal results in EIA, we occasionally experienced this pitfall when testing the reproducibility of the method. Consequently, it is of essential importance to find a reliable technique for fixing anti-IgM, and this point deserves further investigation. Presently, it seems possible to minimize this possible drawback by testing several dilutions of each serum in duplicate by using two different plates with a positive serum control on each plate. 
